BOIMMG

1-(17Z-hexacosenoyl)-2-(9Z,12Z,15Z,18Z,21Z-tetracosapentaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-3,4,5-trisphosphate

BOIMMG ID - 271526

Name - 1-(17Z-hexacosenoyl)-2-(9Z,12Z,15Z,18Z,21Z-tetracosapentaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-3,4,5-trisphosphate

SMILES - CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC/C=C\CCCCCCCC)COP(=O)([O-])O[C@@H]1[C@H](O)[C@H](OP(=O)([O-])[O-])[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)([O-])[O-])[C@H]1O

InChIKey - LNMXIALRXJSAAR-LFHBDKFVSA-G

Formula - C59H99O22P4

Annotated - ✔

SWISS LIPIDS id - SLM:000440998

+Structural Parent

+Precursors

+Components

Lipid name	Formula	BOIMMG ID	Listed
1-(17Z-hexacosenoyl)-2-(9Z,12Z,15Z,18Z,21Z-tetracosapentaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-4,5-bisphosphate	C59H100O19P3	292047	✔
1-(17Z-hexacosenoyl)-2-(9Z,12Z,15Z,18Z,21Z-tetracosapentaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-4-phosphate	C59H101O16P2	281403	✔
1-(17Z-hexacosenoyl)-2-(9Z,12Z,15Z,18Z,21Z-tetracosapentaenoyl)-sn-glycero-3-phospho-1D-myo-inositol	C59H102O13P	26303	✔
CDP-1-(17Z-hexacosenoyl)-2-(9Z,12Z,15Z,18Z,21Z-tetracosapentaenoyl)-sn-glycerol	C62H103N3O15P2	558367	✔
1-(17Z-hexacosenoyl)-2-(9Z,12Z,15Z,18Z,21Z-tetracosapentaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-3-phosphate	C59H101O16P2	270029	✔
1-(17Z-hexacosenoyl)-2-(9Z,12Z,15Z,18Z,21Z-tetracosapentaenoyl)-sn-glycero-3-phosphate	C53H91O8P	21077	✔
Acyl-ACP ((9Z,12Z,15Z,18Z,21Z)-tetracosapentaenoate)	C24H37OSR1	749602	✗
(9Z,12Z,15Z,18Z,21Z)-tetracosapentaenoyl-CoA	C45H68N7O17P3S	236223	✔
1-(17Z-hexacosenoyl)-sn-glycero-3-phosphate	C29H55O7P	6825	✔
Acyl-ACP ((17Z)-hexacosenoate)	C26H49OSR1	749019	✗
Acyl-Phosphates ((17Z)-hexacosenoate)	C26H51O5P	737679	✗